Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Macrophages on De-Novo Chemoresistance of Adenocarcinoma Cells

NCT01921699 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01921699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01921699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Macrophages on De-Novo Chemoresistance of Adenocarcinoma Cells
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2013
Completion date
Not reported
Enrollment
2 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the focus of the study is macrophage-induced chemoresistance in pancreatic carcinoma cells during chemotherapy.